Alongside DITPA, the therapeutic potential of the thyroid hormone analogue triiodothyroacetic acid (Triac) for MCT8 deficiency has extensively been studied. The gene discussed is SLC16A2; the disease is hyperinsulinemic hypoglycemia, familial, 4.